A BILL 
To ensure that ALS patients have access to treatment within 
clinical trials. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘ALS Placebo No More 
4
Act’’. 
5
SEC. 2. AUTHORITY FOR HHS AND AGENCIES TO DEVELOP 
6
RESOURCES AND POLICIES TO PROVIDE AC-
7
CESS TO PROMISING TREATMENTS FOR PA-
8
TIENTS WITH ALS. 
9
The Food and Drug Administration (FDA) and the 
10
National Institutes of Health (NIH) shall collaborate on 
11
19:57 Jan 06, 2020
H5480
lotter on DSKBCFDHB2PROD with BILLS
2 
•HR 5480 IH
any current amyotrophic lateral sclerosis (ALS) trial to 
1
ensure that all patients in treatment and placebo arms are 
2
provided access to the drug. 
3
The FDA shall move expeditiously to implement its 
4
guidance on ALS clinical trials to assure that all trials 
5
going forward shall require treatment arms for all pa-
6
tients. 
7
The Federal Government shall develop incentives to 
8
expand access to investigational therapies for life-threat-
9
ening conditions with fewer than two treatments. 
10
Æ 
19:57 Jan 06, 2020
H5480
lotter on DSKBCFDHB2PROD with BILLS
